MEDIPOST Co., Ltd. (078160.KQ)
KRW 12000.0
(-11.37%)
KRW 12000.0
(-11.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 68.64 Billion KRW | 6.92% |
| 2022 | 64.2 Billion KRW | 17.03% |
| 2021 | 54.85 Billion KRW | 12.82% |
| 2020 | 48.62 Billion KRW | 6.14% |
| 2019 | 45.81 Billion KRW | 3.22% |
| 2018 | 44.38 Billion KRW | 5.05% |
| 2017 | 42.24 Billion KRW | 47.45% |
| 2016 | 28.65 Billion KRW | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 18.03 Billion KRW | 5.8% |
| 2024 Q2 | 17.51 Billion KRW | -2.86% |
| 2023 Q1 | 17.52 Billion KRW | 5.9% |
| 2023 Q2 | 16.65 Billion KRW | -5.0% |
| 2023 Q3 | 17.41 Billion KRW | 4.61% |
| 2023 Q4 | 17.04 Billion KRW | -2.16% |
| 2023 FY | 68.64 Billion KRW | 6.92% |
| 2022 Q2 | 15.95 Billion KRW | 3.75% |
| 2022 FY | 64.2 Billion KRW | 17.03% |
| 2022 Q4 | 16.55 Billion KRW | 1.4% |
| 2022 Q3 | 16.32 Billion KRW | 2.34% |
| 2022 Q1 | 15.37 Billion KRW | 4.13% |
| 2021 Q3 | 13.23 Billion KRW | 0.0% |
| 2021 FY | 54.85 Billion KRW | 12.82% |
| 2021 Q4 | 14.76 Billion KRW | 11.58% |
| 2020 FY | 48.62 Billion KRW | 6.14% |
| 2019 FY | 45.81 Billion KRW | 3.22% |
| 2018 FY | 44.38 Billion KRW | 5.05% |
| 2017 FY | 42.24 Billion KRW | 47.45% |
| 2016 FY | 28.65 Billion KRW | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| HLB Co., Ltd. | 42.9 Billion KRW | -60.005% |
| iNtRON Biotechnology, Inc. | 9.58 Billion KRW | -616.117% |
| BINEX Co., Ltd. | 154.82 Billion KRW | 55.664% |
| Bioneer Corporation | 263.23 Billion KRW | 73.923% |
| Anterogen.Co.,Ltd. | 6.5 Billion KRW | -956.005% |
| CrystalGenomics, Inc. | 4.87 Billion KRW | -1307.004% |
| Helixmith Co., Ltd | 4.2 Billion KRW | -1533.726% |
| Chabiotech Co.,Ltd. | 953.95 Billion KRW | 92.804% |
| Medy-Tox Inc. | 221.12 Billion KRW | 68.957% |
| Peptron, Inc. | 3.34 Billion KRW | -1954.015% |
| Amicogen, Inc. | 159.9 Billion KRW | 57.072% |
| Genexine, Inc. | 4.42 Billion KRW | -1450.684% |
| HLB Therapeutics Co.,Ltd. | 53.74 Billion KRW | -27.71% |
| LegoChem Biosciences, Inc. | 34.14 Billion KRW | -101.03% |
| ALTEOGEN Inc. | 96.52 Billion KRW | 28.884% |
| PharmaResearch Co., Ltd. | 261.01 Billion KRW | 73.701% |
| SillaJen, Inc. | 3.93 Billion KRW | -1642.403% |
| JETEMA, Co., Ltd. | 58.71 Billion KRW | -16.907% |
| OliX Pharmaceuticals,Inc | 17.06 Billion KRW | -302.261% |
| Genomictree Inc. | 3.41 Billion KRW | -1908.274% |
| MedPacto, Inc. | - KRW | -Infinity% |
| D&D Pharmatech | 18.67 Billion KRW | -267.526% |
| EASY BIO,Inc. | 165.38 Billion KRW | 58.495% |
| GI Innovation, Inc. | 5.31 Billion KRW | -1190.561% |